Vansteenkiste JF, Cho B, Vanakesa T, De Pas T, Zielinski M, Kim MS, et al. MAGRIT, a double -blind, randomized, placebo -controlled Phase III study to assess the efficacy of the recmage -a3 + as15 cancer immunotherapeutic as adjuvant therapy in patients with resected mage -a3-positive non -small cell lung cancer (NSCLC). Ann Oncol 2014;25 (suppl_4): iv409 - iv416.